Bariatric Surgery: Clinical Trials

5 trials for Bariatric Surgery, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 4, Recruiting 1
Phase 21Completed 1

Follow Bariatric Surgery: new trials by email Literature Review of Bariatric Surgery trials Research Report on Bariatric Surgery

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents
Injectable semaglutide or injectable tirzepatide, Standard postoperative care - Obesity, Adolescent Obesity
Phase 1RecruitingUniversity of Colorado, Denver402024-10-112026-07-15
Pharmacokinetics of Rivaroxaban After Bariatric Surgery
rivaroxaban 20 mg once daily 8 days - Bariatric Surgery, Morbid Obesity
Phase 1CompletedUniversity Hospital, Brest672020-01-152025-12-03
To Define the Role of GLP-1 for Improving Glucose Homeostasis in Humans Following Gastric Bypass Surgery
Placebo, Lo-Xenin, Hi-Xenin - Bypass, Gastric, Roux-en-Y Gastric Bypass
Phase 1CompletedWashington University School of Medicine132014-07-012018-04-27
Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood Levels
venlafaxine ER (extended-release) 75 mg - Bariatric Surgery, Gastric Bypass
Phase 1CompletedMayo Clinic102013-10-012015-12-23
Regional TAP Block for Bariatric Patients
Transverse abdominal plane block, Ropivacaine - Bariatric Surgery, Transverse Abdominal Plane Regional Blocks
Phase 1 / Phase 2CompletedMontefiore Medical Center232013-04-012019-12-03

Narrower conditions

Body-Weight Trajectory (1)  ·  Obesity (1)  ·  Obesity, Morbid (1)  ·  Pediatric Obesity (1)

Broader conditions

Body Weight (2)  ·  Nutrition Disorders (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Overnutrition (2)  ·  Overweight (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Body Weight Changes (1)  ·  Obesity (1)

Interventions

Albumins (1)  ·  Rivaroxaban (1)  ·  Ropivacaine (1)  ·  Venlafaxine Hydrochloride (1)

Sponsors

Mayo Clinic (1)  ·  Montefiore Medical Center (1)  ·  University Hospital, Brest (1)  ·  University of Colorado, Denver (1)  ·  Washington University School of Medicine (1)

Countries

United States (4)  ·  France (1)

Top investigators

Burton M Wice, PhD (1)  ·  Carrie Krieger, PharmD, RPh (1)  ·  Dominic Reeds, MD (1)  ·  Jaime Moore, MD MPH (1)  ·  Karina Gritsenko, MD (1)

Results publications

PMID 27288245, PMID 39002729

NIH funding

K23HL163480 (1), R01DK088126 (1)